Prof. Satu Mustjoki awarded with Medix 2024 prize
iCAN’s Scientific Director, Professor Satu Mustjoki is awarded with Medix 2024 prize for the study published in the Immunity journal…
iCAN retreat 2024 brought together our community
On 3rd October 2024, the iCAN community gathered for the iCAN retreat, hosting around 250 participants onsite and online, including project researchers, board members,…
Apply now! iCAN Business Developer
Updated on Oct 11: The application period has been extended. The new closing date for applications is October 20. Helsinki…
iCANDOC autumn calls at the universities of Helsinki, Turku, and Oulu
The remaining 59 positions in the national iCANDOC doctoral education pilot will be filled during the autumn calls at the universities of…
The first cohort of iCANDOC doctoral researchers starting in Helsinki
The iCANDOC pilot is a national program under the iCAN Digital Precision Cancer Medicine Flagship, coordinated by the University of…
Lauri A. Aaltonen wins Anders Jahre Award
Professor Lauri A. Aaltonen is the winner of the 2024 Anders Jahre Award for Medical Research for his discoveries of…
Doctoral Defence: Sofie Lundgren, Somatic mutations and aberrant immune responses in aplastic anemia
Before Sofie Lundgren started her MD/PhD studies at the University of Helsinki, a few landmark studies on clonal hematopoiesis had…
Call for new iCAN subproject proposals 2025-2026 open now
The iCAN Flagship Project had a large call in 2022 for new subproject applications for the second term (2023 – 2026)….
New iCANDOC Precision Cancer Medicine doctoral researchers starting
A total of 93 doctoral researchers were recently selected in calls at the University of Helsinki, Tampere University, and University…
iCAN kansallinen ohjelma käynnistyi: 2,5 miljoonan euron rahoitus alueellisille syöpäkeskuksille biopankkihankkeisiin
Kansallisen syöpäkeskus FICANin puitteissa käynnistyvät hankkeet tulevat vahvistamaan syövän molekyyliprofilointia koko Suomessa. Hankkeet ovat osa iCAN-tutkimushanketta. Tavoitteena on kehittää valmiuksia syövän…
End of content
End of content